Nantahala Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8M Hold
68,394,000
0.96% 26
2026
Q1
$38.2M Hold
68,394,000
1.41% 17
2025
Q4
$53.6M Hold
68,394,000
1.77% 10
2025
Q3
$44.4M Hold
68,394,000
1.54% 13
2025
Q2
$50.5M Buy
68,394,000
+57,000,000
+500% +$32.4M 1.98% 8
2025
Q1
$5.36M Hold
11,394,000
0.21% 66
2024
Q4
$5.05M Hold
11,394,000
0.22% 78
2024
Q3
$7.44M Buy
11,394,000
+7,814,000
+218% +$5.17M 0.38% 57
2024
Q2
$2.26M Sell
3,580,000
-420,000
-11% -$335K 0.13% 87
2024
Q1
$4.68M Hold
4,000,000
0.27% 66
2023
Q4
$4.52M Hold
4,000,000
0.27% 64
2023
Q3
$4.4M Buy
+4,000,000
New +$4.29M 0.38% 58

Other funds holding XTNT

Nantahala Capital Management's XTNT Position: Q2 2026 in Review

Nantahala Capital Management held its Xtant Medical Holdings (XTNT) position steady in Q2 2026 at 68,394,000 shares worth $28.8M. The position accounts for 0.96% of the portfolio, ranked #26.

Nantahala Capital Management first reported a position in XTNT in Q3 2023 and has held it in 12 quarters since. The position peaked at $53.6M in Q4 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

  • Nantahala Capital Management held 68,394,000 shares of Xtant Medical Holdings worth $28.8M as of Q2 2026.
  • Nantahala Capital Management left its Xtant Medical Holdings share count unchanged in Q2 2026.
  • Xtant Medical Holdings made up 0.96% of Nantahala Capital Management's portfolio in Q2 2026, its #26 holding.
  • Nantahala Capital Management first reported a position in Xtant Medical Holdings in Q3 2023 and has held it in 12 quarters since.
  • Nantahala Capital Management's Xtant Medical Holdings position peaked at $53.6M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.